We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
TAKKT AG Shareholders Back Strategy Amid Challenges
about 2 hours ago
Partners Group AGM Approves Dividend, Board Re-Elections
about 2 hours ago
Beeline Holdings Q1 Revenue Doubles, Eyes $100M Run Rate
about 3 hours ago
Sunshine Biopharma Raises $6M in Public Offering for Drug Pipeline
about 7 hours ago
SoundHound AI Q1 Revenue Soars 52%, Reaffirms Guidance
about 7 hours ago
Why Silver Falls Harder Than Gold: Liquidity and Dual Demand
about 7 hours ago
HR News
Steyr Motors Appoints Bjorn Krausmann as CFO to Drive Growth
1 day ago
HR Research Institute Forms 2026 Employee Productivity and Engagement Advisory Board
1 day ago
HR.com Honors 2026 HR Tech Innovation Award Winners
6 days ago
CHRO of the Year Awards 2026 Winners Announced at HRO Today Forum
7 days ago
Liveops Revolutionizes Customer Support with Flexible Outsourced Call Center Model
8 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 10 days
Global Fashion Group AGM Approves All Resolutions, Including Share Buyback Authorization
about 1 hour ago
TAKKT AG Shareholders Back Strategy Amid Challenges
about 2 hours ago
Crypto News
Saudi Arabia Pushes Tokenization to Transform Economy
1 day ago
Trump Admin Curbs State Crypto Oversight, Sparks Debate
1 day ago
ECGI Holdings Launches Rezy.Fi Investor Onboarding for Tokenized Mortgages
1 day ago
Perpetuals.com CEO Unveils AI Trading Platform to Bridge Crypto Gap
5 days ago
Senate Unveils 309-Page CLARITY Act to Regulate Crypto
5 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 10 days
Cardio Diagnostics CEO Reveals India Expansion and Medicare Progress on Podcast
about 4 hours ago
Datavault AI and Wellgistics Launch $4B DelivMeds AI Healthcare Platform
about 4 hours ago
Technology News
Sunshine Biopharma Raises $6M in Public Offering for Drug Pipeline
about 7 hours ago
SoundHound AI Q1 Revenue Soars 52%, Reaffirms Guidance
about 7 hours ago
Why Silver Falls Harder Than Gold: Liquidity and Dual Demand
about 7 hours ago
Forward Industries Q2 Revenue Soars 4X, Strengthens Solana Treasury
about 7 hours ago
Quarterhill Secures $60M Credit Facility to Fuel Growth and Innovation
about 7 hours ago
Events & Conferences
Global Fashion Group AGM Approves All Resolutions, Including Share Buyback Authorization
about 1 hour ago
Western Star Resources to Present at Commodities Global Expo 2026
about 11 hours ago
B2i Digital Named Official Marketing Partner for Centurion One Capital's Miami Summit
about 23 hours ago
Wearable Devices and Meta-Bounds to Showcase AR Neural Integration at AWE 2026
1 day ago
Oragenics to Present at Sidoti Micro-Cap Virtual Investor Conference
1 day ago